Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1-Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00376935
What this trial is testing

Effectiveness of Palifermin in Increasing CD4 Counts in Treatment-Experienced HIV Infected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 99
Large-scale testing (Phase 3)Study completedNCT00098748
What this trial is testing

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected Subjects

Who this might be right for
HIV Infections
ViiV Healthcare 190
Not applicableUnknownNCT03164135
What this trial is testing

Safety of Transplantation of CRISPR CCR5 Modified CD34+ Cells in HIV-infected Subjects With Hematological Malignances

Who this might be right for
HIV-1-infection
Affiliated Hospital to Academy of Military Medical Sciences 5
Large-scale testing (Phase 3)Study completedNCT00440947
What this trial is testing

Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 515
Early research (Phase 1)Study completedNCT05165550
What this trial is testing

Study of Single Ascending Doses of Elsulfavirine to Evaluate the Safety, Tolerability, and Pharmacokinetics of Elsulfavirine and Its Active Metabolite VM-1500A in Healthy Subjects

Who this might be right for
HIV-1-infection
Viriom 24
Not applicableStudy completedNCT04661813
What this trial is testing

Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV

Who this might be right for
HIV-1-infectionHypertension
Case Western Reserve University 81
Not applicableStudy completedNCT01154543
What this trial is testing

Safety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital Herpes

Who this might be right for
HIV PositiveHerpes Simplex, Genital
Holdsworth House Medical Practice 42
Testing effectiveness (Phase 2)Study completedNCT00743340
What this trial is testing

Rollover Study Protocol for Pediatric Patients in South Africa for Continued Access to Emtricitabine

Who this might be right for
HIV-1 Infection
Gilead Sciences 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT02494986
What this trial is testing

A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in Rilpivirine Pediatric Studies

Who this might be right for
Human Immunodeficiency Virus Type 1
Janssen Sciences Ireland UC 48
Large-scale testing (Phase 3)Ended earlyNCT01145417
What this trial is testing

Pregabalin Trial In HIV Neuropathic Pain

Who this might be right for
HIV-1 InfectionNeuropathic Pain
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 217
Testing effectiveness (Phase 2)UnknownNCT03539224
What this trial is testing

Antiretroviral Treatment Guided by Proviral Genotype: Pilot Trial of Proof of Concept.

Who this might be right for
HIV-1-infection
Instituto de Investigación Hospital Universitario La Paz 41
Early research (Phase 1)Study completedNCT00002008
What this trial is testing

An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia

Who this might be right for
HIV InfectionsCytopenias
Sandoz
Large-scale testing (Phase 3)Active Not RecruitingNCT02938520
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants

Who this might be right for
HIV Infections
ViiV Healthcare 631
Large-scale testing (Phase 3)Study completedNCT02071082
What this trial is testing

Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected Adults

Who this might be right for
HIVHBV
Gilead Sciences 79
Not applicableStudy completedNCT00000896
What this trial is testing

Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)UnknownNCT01793818
What this trial is testing

Evaluation on Seropositive Patients of a Synthetic Vaccine Targeting the HIV Tat Protein

Who this might be right for
AIDS
BIOSANTECH 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07816250
What this trial is testing

A Phase 2b Study Evaluating VH4011499 Capsid Inhibitor Long-Acting Injectable Plus Cabotegravir in Treatment Naïve Adults (CINERGY)

Who this might be right for
HIV Infections
ViiV Healthcare 200
Early research (Phase 1)Study completedNCT00141024
What this trial is testing

Safety of and Immune Response to the Experimental Preventive HIV Vaccine, EP HIV-1090, in Healthy, HIV-1 Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 84
Testing effectiveness (Phase 2)Study completedNCT00903682
What this trial is testing

A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients

Who this might be right for
HIV InfectionHIVAcquired Immunodeficiency Syndrome
Janssen-Cilag International NV 157
Not applicableActive Not RecruitingNCT01466582
What this trial is testing

Comorbidity and Aging With HIV

Who this might be right for
HIV-1-infectionComorbidityAgeing
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1,148
Next Page